Interchange Capital Partners’s Boston Scientific BSX Stock Holding History

Interchange Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,319	Closed	-$215K	–	437
2026 Q1	$215K	Sell	2,319 -3,168	-58%	-$253K	0.07%	253
2025 Q4	$523K	Buy	5,487 +1,122	+26%	+$110K	0.1%	188
2025 Q3	$426K	Buy	4,365 +1,790	+70%	+$185K	0.08%	207
2025 Q2	$277K	Buy	2,575 +278	+12%	+$28.1K	0.06%	235
2025 Q1	$232K	Buy	+2,297	New	+$231K	0.06%	243
2021 Q1	–	Sell	-287	Closed	-$10K	–	343
2020 Q4	$10K	Buy	+287	New	+$10.3K	0.01%	782

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Interchange Capital Partners's BSX Position: Q2 2026 in Review

Interchange Capital Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 2,319 shares — an estimated $215K sold.

Interchange Capital Partners first reported a position in BSX in Q4 2020 and held it in 6 quarters. The position peaked at $523K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Interchange Capital Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Interchange Capital Partners sold 2,319 Boston Scientific shares in Q2 2026, an estimated $215K.
Interchange Capital Partners first reported a position in Boston Scientific in Q4 2020 and held it in 6 quarters.
Interchange Capital Partners's Boston Scientific position peaked at $523K in Q4 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.